Johnson & Johnson (JNJ) – Downgrades
-
Fate Therapeutics (FATE) collapses 55% after terminating Janssen deal, earns several downgrades
-
Today's Most Important Downgrades
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to JNJ Stock Lookup